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Background/aim: Evidence for the effectiveness of splinting in thumb carpometacarpal osteoarthritis is limited. We aimed to evaluate
the effects of a prefabricated carpometacarpal metacarpophalangeal immobilization splint on pain, hand function, and hand strength in
patients with early-stage thumb carpometacarpal osteoarthritis.
Materials and methods: Sixty-three hands with stage 1 or 2 thumb carpometacarpal osteoarthritis were enrolled in the study. The
nonsplint group received oral information about how to accommodate daily activities. The splint group was given a prefabricated
carpometacarpal metacarpophalangeal immobilization splint for 6 weeks. Pain was evaluated using the Australian/Canadian
Osteoarthritis Hand Index (AUSCAN). Hand functions were evaluated using the AUSCAN and the Quick Disabilities of Arm, Shoulder
and Hand (Q-DASH) questionnaire. Grip and pinch strengths were measured using a hydraulic dynamometer and a hydraulic pinch
gauge.
Results: The AUSCAN pain, stiffness, function, total scores, and Q-DASH scores were significantly decreased in the splint group
compared to the nonsplint group. Significant increments in grip and pinch strengths were detected in the splint group compared to the
nonsplint group.
Conclusion: The prefabricated carpometacarpal metacarpophalangeal immobilization splint is effective in improving pain, hand
function, and hand strength in patients with thumb carpometacarpal osteoarthritis.
Key words: Thumb osteoarthritis, splint, hand function

1. Introduction
Thumb carpometacarpal (CMC) joint osteoarthritis (OA)
is the second most common hand OA. Patients with
thumb CMC OA often present with pain, instability, and
functional limitations. Pain and instability in the thumb
may cause a reduction in the ability to perform activities
of daily living such as grasping, pinching, and turning. The
stability of the thumb CMC joint is essential to reduce pain
and difficulty in daily living activities [1].
Treatment of thumb CMC OA consists of conservative
therapeutic interventions and surgical interventions.
Conservative therapy includes joint protection
principles, splinting, pain control, exercise, nonsteroidal
antiinflammatory drugs, corticosteroid injections, and
physical therapy. Splinting is the mainstay of conservative
therapy. The aims of splinting are to improve the stability
of the thumb CMC joint by providing external support,
to increase hand function, and to reduce pain. Increased
stabilization of the first CMC joint prevents dorsal

subluxation and further joint deformity, provides pain
control, and maintains hand function [1–5].
The choice of splint design depends on which joint
needs to be immobilized, the degree of OA, coexisting
hand conditions, patient’s functional status, and patient
preference [1,4]. Static splints are the most commonly
used splints in thumb CMC OA [1]. The types of static
splints are the wrist-CMC-MCP (metacarpophalangeal)
immobilization splint (long opponens splint), the CMCMCP immobilization splint (short opponens splint), and
the CMC immobilization splint [2].
Evidence for the effectiveness of different types of
splints in thumb CMC OA is limited [6–10]. The European
League Against Rheumatism (EULAR) reported that
placebo-controlled or nonsplint-controlled research
evidence is required [11]. To our knowledge, there is only
one randomized controlled trial with a nonsplint control
in the literature. In this study, Rannou et al. studied the
effects of a custom-made rigid CMC-MCP splint in
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patients with both early and advanced thumb CMC OA
[10]. There is no study to assess the prefabricated CMCMCP splint in the treatment of early-stage thumb CMC
OA. The prefabricated CMC-MCP splint is readily available
in varying sizes and more inexpensive than the custommade CMC-MCP splint. Therefore, we aimed to evaluate
the effects of a prefabricated CMC-MCP immobilization
splint on pain, hand function, hand strength, and quality
of life in patients with stage 1 or 2 thumb CMC OA.
In previous studies, stabilization of the thumb CMC
joint in palmar abduction and the MCP joint in flexion
with the short opponens splint was recommended in
both early and advanced stage thumb CMC OA [12–14].
According to these studies, we preferred the prefabricated
CMC-MCP immobilization splint in patients with earlystage OA. This type of splint provides adequate support to
the CMC and MCP joints while allowing functional use of
the hand. In addition, the prefabricated CMC-MCP splint
is readily available in varying sizes and is less expensive
than custom-made splints. To our knowledge, there is no
study to assess the prefabricated CMC-MCP splint in the
treatment of early-stage thumb CMC OA. Therefore, we
aimed to evaluate the effects of the prefabricated CMCMCP immobilization splint on pain, hand function, hand
strength, and quality of life in patients with stages 1 or 2
thumb CMC OA.
2. Materials and methods
Sixty-six patients with 80 hands affected with stage 1 or 2
thumb CMC OA who were admitted to an outpatient hand
clinic between July 2017 and January 2018 were enrolled in
the study. The diagnosis of thumb CMC OA was made by a
hand surgeon based on history, physical examination, and
X-ray. Patients with thumb CMC OA were staged according
to the Eaton-Littler-Burton classification system based
on radiographic findings. The exclusion criteria were: 1)
prior treatment for thumb CMC OA within the previous
6 months; 2) posttraumatic OA; 3) previous hand surgery;
4) inflammatory hand involvement; 5) neurologic hand
involvement; 6) clinical signs of carpal tunnel syndrome,
Dupuytren’s contracture, de Quervain tenosynovitis, and
trigger finger; 7) peripheral vascular disease; 8) cognitive
dysfunction; 9) skin disease interfering with wearing a
splint; 10) pregnancy.
This study was performed with the approval of the
local ethics committee in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki
and all subsequent revisions. All patients provided written
informed consent to participate.
Eighty hands were randomly assigned following a
simple randomization procedure (computed random
numbers) to a splint group (n = 40) and a nonsplint control
group (n = 40). Seventeen hands were excluded from the
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study analysis. The remaining 63 hands were analysed. The
flow chart of the study design is shown in Figure 1.
2.1. Interventions
The splint group was given a prefabricated splint program
and oral information about how to accommodate activities
of daily living (to use larger joints during daily living
activities, to carry items on two flat hands rather than
gripping with the fingers, to carry large or heavy items with
two hands, to push items rather than carrying, to push up
from a chair using the palm of the hand) throughout the
study period. A prefabricated CMC-MCP immobilization
splint (short opponens splint) was recommended for the
patients in the splint group. This splint was made from
neoprene with a removable metal stay. The metal stay
extended along the thumb to support the first CMC joint
in 30° palmar abduction and the MCP joint in 15° flexion
(Figure 2). We assessed the suitability of the splint before
starting usage. The patients were instructed to wear their
splints all the time (daytime and night-time) as much as
possible for the first 3 weeks and then only during painful
activities for another 3 weeks. A maximum of 1500 mg
of paracetamol per day was allowed to be taken for pain
throughout the study.
The nonsplint control group received only oral
information about how to accommodate activities of
daily living throughout the study period. Paracetamol was
allowed to be taken for pain throughout the study.
2.2. Assessments
The demographic and clinical characteristics of the patients
at baseline were recorded. We used the Kapandji finger
opposition test to assess the opposition of the thumb. The
patients were instructed to touch the affected thumb to 10
points on the same hand.
Wrist/hand pain and functions were evaluated using
the Australian/Canadian Osteoarthritis Hand Index
(AUSCAN). It is a self-report assessment of pain (5 items),
stiffness (1 item), and hand function (9 items) in OA of the
hand. Each item is scored on a 5-point scale (0 = none, 4
= extreme) [15]. Higher scores indicate worse symptoms
and function. The AUSCAN has been shown to be valid
and reliable in measuring symptoms and hand function in
hand OA [16].
We also used the Quick Disabilities of Arm, Shoulder
and Hand (Q-DASH) questionnaire to assess hand
functions. It has 11 items and each item is scored from
1 to 5. Higher scores indicate lower functional levels.
The validity and reliability of the Turkish version of the
Q-DASH have been done by Düger et al. [17].
Grip strength was measured using a Jamar hydraulic
hand dynamometer. Lateral pinch, 2- point pinch, and
3-point pinch strengths were measured using a Jamar
hydraulic pinch gauge (Bolingbrook, IL, USA). Patients
were seated with shoulder adducted, elbow 90° flexed,
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Figure 1. Flow chart of the study design.

forearm and wrist in neutral position. Patients were
encouraged to press as firmly as possible. Three consecutive
measurements were performed. The average of the three
measurements was recorded in kilograms (kg) [18].
Patients’ quality of life was measured using the
Nottingham Health Profile (NHP). It is a self-report
questionnaire with 6 dimensions of health: physical
mobility (8 items), pain (8 items), sleep (8 items), energy
(8 items), social isolation (5 items), and emotional
reaction (9 items). Patients were asked whether or not
each item applied to them. Positive answers were given
the appropriate weight according to their relative severity.
Each dimension score ranges from 0 to 100. Lower scores
indicate better quality of life. The Turkish validity and
reliability study of the scale was performed by Kucukdeveci
et al. [19].
All patients were asked to rate their overall
satisfaction with the splint using a 10 cm visual analogue
scale (VAS) at the end of the intervention.
2.3. Follow-up
The authors called the patients weekly to assess adherence
to wearing the splint. Patients were evaluated before the
intervention and at the end of 6 weeks. All assessments
were performed by the same clinician who was blind to
the treatment.
2.4. Statistics
The sample size was determined based on a previous study.
To achieve a 2 cm reduction on a 10 cm VAS pain scale

in the splint group, we calculated at least 23 patients per
group using the 5% significance level and 80% statistical
power [20]. The Kolmogorov–Smirnov test was used to
evaluate the distribution of normality. We performed
the unpaired t-test for normally distributed data and the
Mann–Whitney U test for nonnormally distributed data
to compare the demographic characteristics, baseline
measurements, and change scores between the groups.
We used the paired samples t-test for normally distributed
data and the Wilcoxon sign rank test for nonnormally
distributed data to compare the difference between the
baseline and posttreatment values within the groups. The
Pearson Chi-square test was used to analyse categorical
data. SPSS version 17 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses. P values less than 0.05 were
considered to represent a significant difference.
3. Results
There was no significant difference in baseline demographic
and clinical characteristics of the patients between groups.
The baseline demographic and clinical characteristics of
the patients are shown in Table 1. A total of 11% of patients
in the splint group and 14% of patients in the nonsplint
group used paracetamol for pain relief throughout the
study. There was no significant difference between the
groups (P = 0.04).
The AUSCAN pain, stiffness, function, and total scores
were significantly decreased in the splint group at the
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< 0.05). Only the NHP total score decreased significantly
in the nonsplint group after the treatment (P < 0.05).
The change in NHP total score for the splint group was
significantly better than that for the nonsplint group
(–117.7 ± 59.5 and –35.9 ± 7.1, respectively; P = 0.002).
The NHP scores of the groups are shown in Table 2.
The mean satisfaction score of patients with
splint usage was 7.3 ± 1.7 (0–10 cm VAS).
Scores greater than or equal to 5 were accepted as high
satisfaction with the splint. According to this, 77% of the
patients in the splint group had a high satisfaction level.
A total of 23% of the patients in the splint group reported
that the splint was uncomfortable and restricted their daily
activities.

Figure 2. A prefabricated CMC-MCP immobilization splint.

end of the treatment (P < 0.05). In the nonsplint group,
there were no statistically significant differences in the
AUSCAN pain, stiffness, function, and total scores at the
end of treatment. The Q-DASH scores were also decreased
in the splint group after treatment (P < 0.05), whereas
no significant changes occurred in the nonsplint group.
We did not find a significant change in Kapandji scores
of patients after treatment in both groups. The AUSCAN,
Q-DASH, and Kapandji scores of the groups are shown in
Table 2.
In the splint group, we detected significant increments
in grip strength, lateral pinch, 2-point pinch, and 3-point
pinch strengths at the end of the treatment (P < 0.05).
However, no significant increments in grip strength and
pinch strength were detected in the nonsplint group after
treatment. Grip strength and pinch strength of the groups
are shown in Table 2.
The NHP pain, energy level, emotional reaction, sleep,
social isolation, physical mobility, and total scores of the
splint group decreased significantly after the treatment (P
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4. Discussion
Although different types of splints were evaluated in the
previous studies, what is the optimal splint type in the
treatment of thumb CMC OA is controversial [1,3]. To the
best of our knowledge, this is the first study to compare
the effects of a prefabricated CMC-MCP immobilization
splint for a duration of 6 weeks with no splinting in patients
with early-stage thumb CMC OA. In the present study, we
detected that the prefabricated CMC-MCP immobilization
splint is an effective treatment intervention for improving
pain, hand function, and quality of life in patients with
early-stage thumb CMC OA.
There is no evidence on which type of splint was
more effective in pain relief and enhancing the function
of the thumb CMC OA. Bongi et al. splinted 13 patients
with thumb CMC OA in a custom-made short opponens
splint for 1 month and detected significant pain relief at
the end of the intervention [9]. Weiss at al. evaluated the
effects of rigid custom-made CMC immobilization splint
and prefabricated CMC-MCP immobilization splint in
25 hands with stage 1 or 2 thumb CMC OA. Both pain
and function were improved more with the prefabricated
CMC-MCP immobilization splint [7]. These findings are
consistent with the results of the present study, in which the
prefabricated CMC-MCP immobilization splint provided
significant pain relief and functional improvement
compared with no splint. On the contrary, Sillem et al.
showed that custom-made CMC immobilization splint
was significantly better than prefabricated CMC-MCP
immobilization splint to reduce pain. They showed no
improvement in hand function after wearing the splints for
4 weeks [3]. Rannou et al. found no significant differences
in pain and disability between the custom-made rigid
CMC-MCP immobilization splint group and the nonsplint
group at 4 weeks [10]. The different results were attributed
to the differences in sample size, splint materials, splint
wearing schedule, stage of thumb CMC OA, and measured
variables.

GENÇAY CAN and TEZEL / Turk J Med Sci
Table 1. Baseline demographic and clinical characteristics of the patients [(mean ± SD) or median
(min-max)].
Splint group
(n = 35)

Nonsplint group
(n = 28)

P

Age

56.1 ± 7.5

56.6 ± 9.2

0.67

Sex
Male
Female

8.3%
91.7%

10.7%
89.3%

0.55

Education (years)

6.5 ± 1.2

6.8 ± 1.4

0.72

Occupation
Housewife
Worker
Retired

77.8%
13.9%
8.3%

78.6%
14.3%
7.1%

0.98

Dominant hand side
Right
Left

97.2%
2.8%

92.9%
7.1%

0.58

Symptomatic hand
Dominant
Non-dominant

50%
50%

46.4%
53.6%

0.53

Symptom duration (months)

12(3-60)

12(1-36)

0.70

AUSCAN
Pain
Stiffness
Function
Total

13.5 ± 3.7
1(0–4)
24.1 ± 7.8
39.2 ± 10.8

13.7 ± 4.1
1(0–3)
23.1 ± 7.6
37.9 ± 11.4

0.88
0.81
0.91
0.95

Q-DASH

53.2 ± 16.1

48.2 ± 18.3

0.28

Kapandji (0–10)

9.5 ± 1.6

9.8 ± 0.4

0.07

Grip strength (kg)

14.3 ± 6.7

13.8 ± 5.7

0.41

Lateral pinch (kg)

6.4 ± 1.9

6.2 ± 1.9

0.99

2-point pinch (kg)

6.1 ± 1.9

5.6 ± 1.8

0.61

3-point pinch (kg)

6.2 ± 2.1

5.7 ± 1.8

0.32

NHP
Pain
Energy level
Emotional reaction
Sleep
Social isolation
Physical mobility
Total

80(0–100)
100(0–100)
83.7(0–100)
64.4 ± 33.1
42(0–100)
45.1 ± 29.9
375.9 ± 148.9

80(0–100)
100(0–100)
46(0–100)
41.4 ± 35.1
17.5(0–100)
43.9 ± 25.1
309.1 ± 151.1

0.59
0.49
0.06
0.45
0.29
0.47
0.87

SD: standard deviation; AUSCAN: Australian Canadian Osteoarthritis Hand Index,
Q-DASH: Disabilities of Arm, Shoulder and Hand questionnaire, NHP: Nottingham Health Profile.

The evidence regarding the use of splinting to improve
hand strength is insufficient [3,7,10]. We found significant
increments in grip strength, lateral pinch strength,
2-point pinch strength, and 3-point pinch strength
in the splint group compared to the nonsplint group
at the end of the sixth week. We believe the increase in

grip and pinch strengths observed in the splint group
was due to a reduction in pain and an improvement in
thumb CMC joint stabilization. Our results differ from
the previous studies in regard to the effect of splinting on
the grip and pinch strengths. Weiss et al. found that both
custom-made CMC immobilization and prefabricated
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Table 2. The AUSCAN, Q-DASH, Kapandji, NHP, hand grip strength and pinch strength values of the patients[(mean ± SD) or median
(min-max)]
Splint Group
(n=35)

Non-Splint Group
(n=28)

Pre-treatment

Post-treatment p

Pre-treatment

Post-treatment p

AUSCAN Pain

13.5±3.7

7.3±4.1

<0.001*

13.7±4.1

12.3±5.3

0.06

AUSCAN Stiffness

1(0-4)

0(0-4)

<0.001*

1(0-3)

0(0-3)

0.81

AUSCAN Function

24.1±7.8

11.8±7.2

<0.001*

23.1±7.6

20.4±9.4

0.11

AUSCAN Total

39.2±10.8

19.3±11.2

<0.001*

37.9±11.4

33.6±15.2

0.06

Q-DASH

53.2±16.1

25.2±15.8

<0.001*

48.2±18.3

44.6±22.6

0.23

Kapandji (0-10)

9.5±1.6

9.5±1.2

0.07

9.8±0.4

9.8±0.4

Grip strength (kg)

14.3±6.7

17.2±6.6

<0.001*

13.8±5.7

14.1±5.8

0.47

Lateral pinch (kg)

6.4±1.9

7.8±2.7

0.002*

6.2±1.9

6.1±2.2

0.33

2-point pinch (kg)

6.1±1.9

7.4±2.9

0.001*

5.6±1.8

5.5±1.6

0.55

3-point pinch (kg)

6.2±2.1

7.6±3.2

0.002*

5.7±1.8

5.8±2.2

0.42

NHP Pain

80(0-100)

53.4(0-100)

0.004*

80(0-100)

59.5(0-100)

0.13

NHP Energy level

100(0-100)

63.2(0-100)

0.01*

100(0-100)

100(0-100)

0.06

NHP Emotion reaction

83.7(0-100)

38.7(0-100)

<0.001*

46(0-100)

42.4(0-100)

0.07

NHP Sleep

64.4±33.1

39.9±34.1

<0.001*

41.4±35.1

39.3±35.1

0.59

NHP Social isolation

42(0-100)

0(0-100)

0.002*

17.5(0-100)

0(0-100)

0.13

NHP Physical mobility

45.1±29.9

36.1±20.6

0.02*

43.9±25.1

40.8±21.8

0.22

NHP Total

375.9±148.9

257.8±142.1

<0.001*

309.1±151.1

273.1±156.4

0.009*

AUSCAN: Australian Canadian Osteoarthritis Hand Index, Q-DASH: Disabilities of Arm, Shoulder and Hand questionnaire, NHP:
Nottingham Health Profile,
SD: standard deviation, *: statistically significant

CMC-MCP immobilization splints did not significantly
alter the pinch strengths as compared with pretreatment
values [7]. Sillem et al. reported no improvement in
grip and pinch strengths after wearing the prefabricated
CMC-MCP immobilization splint in patients with thumb
CMC OA [3]. Rannou et al. did not detect a significant
difference in pinch strength between the custom-made
rigid CMC-MCP immobilization splint group and the
nonsplint group [10]. It was difficult to compare the
results of previous studies with the present study because
of differences in study samples, splint materials, and
duration of splint use.
Besides pain, physical function, and strength, it is
also important to assess the quality of life of the patients
with hand and thumb OA. Hand and thumb OA has a
high impact on the quality of life of patients [21]. To our
knowledge, there is no study in the literature to evaluate
the effects of splinting on the quality of life of patients
with thumb CMC OA. We assessed the effects of splinting
on the quality of life of patients using NHP and detected
that splinting is effective in improving the quality of life
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of patients due to pain relief and increased hand function.
In the present study, the patients rated their splint
satisfaction using a 10-cm VAS. The mean satisfaction
score of the patients was 7.3. When a score of 5.0 or
more was accepted as high satisfaction, 77% of patients
had high satisfaction with the prefabricated CMC-MCP
immobilization splint. Seventy-seven percent of patients
reported that daily activities were easier to perform while
wearing the splint, whereas 23% of patients reported
difficulty in performing daily activities. This result is in
line with those reported by other studies [3,7]. Weiss et
al. reported that three-quarters of patients with thumb
CMC OA preferred the prefabricated CMC-MCP
immobilization splint [7]. In another study, 63% of patients
preferred the prefabricated CMC-MCP immobilization
splint to the custom-made CMC immobilization splint
due to its comfortable usage [3].
The information about wearing splint schedules for
thumb CMC OA in the literature is contradictory [8,9,13].
Swigart et al. offered to wear the splint continuously for
3 weeks and then only during the heaviest activities for
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3 weeks [8]. Bongi et al. instructed to wear the splint for
5–6 h per day and at night during 4 weeks, then during
heavy activities only [9]. Glickel recommended the splint
only during the day for pain relief [13]. In the present
study, patients were instructed to wear the splint all the
time as much as possible during the first 3 weeks for
immediate reduction of pain. After this period, the splint
was recommended only during activities of daily living
that cause pain to support the hand functions and to
reduce pain. We found that splinting is a well-tolerated
conservative treatment in patients with thumb CMC OA.
The study has some limitations. First, the follow-up
time of the study (6 weeks) was short. Longer-term followup of patients after the end of the scheduled treatment
period will provide more important information on
the persistent effects. Second, we did not evaluate the
effects of another type of splint in patients with thumb
CMC OA. A comparison of the effects of different types

of splints with no splinting will provide a more valuable
contribution to the literature.
5. Conclusions
In conclusion, we evaluated the effects of a prefabricated
CMC-MCP immobilization splint in patients with thumb
CMC OA. We detected that this type of splint is effective
in improving pain, hand function, grip strength, pinch
strength, and quality of life at the end of a 6-week usage
period. Future randomized controlled studies with larger
sample sizes and longer follow-up periods are needed to
confirm the effects of splinting in the treatment of thumb
CMC OA.
Informed Consent
The study protocol received institutional review board
approval. All participants provided informed consent in
the format required by the relevant authorities.
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